Selected article for: "financial support and study aim"
Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017
  • Document date: 2017_11_7
    • ID: roslkxeq_182
    Snippet: Disclosures: Disclosures to report. Claudia Reusch was consultant for Boehringer Ingelheim and Novartis Animal Health and is currently consultant for Dechra Limited. She has received financial support for her endocrine research from various companies such as Nestl e Purina, Hills, Provet, Antlia SA, Glycemicon and from the clinical studies fund of the ECVIM-CA and from the Society of Comparative Endocrinology. Glycemic parameters, such as fructos.....
    Document: Disclosures: Disclosures to report. Claudia Reusch was consultant for Boehringer Ingelheim and Novartis Animal Health and is currently consultant for Dechra Limited. She has received financial support for her endocrine research from various companies such as Nestl e Purina, Hills, Provet, Antlia SA, Glycemicon and from the clinical studies fund of the ECVIM-CA and from the Society of Comparative Endocrinology. Glycemic parameters, such as fructosamine, glycosylated hemoglobin and serial glucose measurements (SGMs), are always to be interpreted in light of the clinical signs being exhibited by diabetic pets. Sample artifacts, assay-issues, inter-day variation and stress can yield deceiving laboratory results. Likewise, the clinical history suffers from inter-person variation, due to varying ways of asking or answering questions, interpreting non-standardized language, forgetting questions and lack of quantification. The aim of this study was to evaluate the newly designed simple Diabetic Clinical Score (DCS) in diabetic dogs. The DCS was previously validated for use in diabetic cats.

    Search related documents:
    Co phrase search for related documents
    • clinical history and glycosylated hemoglobin: 1
    • clinical history and laboratory result: 1, 2
    • clinical history and question answering: 1
    • clinical history and study aim: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51
    • clinical sign and study aim: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • clinical studies fund and Dechra Limited consultant: 1, 2
    • clinical studies fund and endocrine research: 1, 2
    • clinical studies fund and financial support: 1, 2
    • clinical studies fund and Novartis Animal Health Boehringer Ingelheim consultant: 1, 2